Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E.
about
The 17D-204 Vaccine Strain-Induced Protection against Virulent Yellow Fever Virus Is Mediated by Humoral Immunity and CD4+ but not CD8+ T CellsGuiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccineActivation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genesYellow fever 17D as a vaccine vector for microbial CTL epitopesBroadening the horizons for yellow feverLive attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopesYellow fever vaccine induces integrated multilineage and polyfunctional immune responsesComprehensive analysis of T cell epitope discovery strategies using 17DD yellow fever virus structural proteins and BALB/c (H2d) mice modelDynamics of the CD8 T-cell response following yellow fever virus 17D immunizationWanted, dead or alive: New viral vaccinesImmune activation alters cellular and humoral responses to yellow fever 17D vaccineT-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifsPre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow feverAdaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccinationMeta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology.Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.Human leukocyte antigen (HLA) class I restricted epitope discovery in yellow fewer and dengue viruses: importance of HLA binding strengthYellow fever: a reemerging threatWest Nile virus vaccines.Yellow fever: the recurring plague.Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunityRecombinant yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruziBiological and immunological characterization of recombinant Yellow Fever 17D viruses expressing a Trypanosoma cruzi Amastigote Surface Protein-2 CD8+ T cell epitope at two distinct regions of the genomeDevelopment of antigen-specific memory CD8+ T cells following live-attenuated chimeric West Nile virus vaccinationMathematical modeling provides kinetic details of the human immune response to vaccination.CD8+ T cells complement antibodies in protecting against yellow fever virus.Dynamics of the cytotoxic T cell response to a model of acute viral infectionA Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after VaccinationThe yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.Yellow fever vaccine.Use it or lose it: establishment and persistence of T cell memory.Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins.Insights into human CD8(+) T-cell memory using the yellow fever and smallpox vaccines.The sample processing time interval as an influential factor in flow cytometry analysis of lymphocyte subsets.Attenuation and immunogenicity of recombinant yellow fever 17D-dengue type 2 virus for rhesus monkeys.Lymphocyte subset analyses in healthy adults vaccinated with yellow fever 17DD virus.How Can Elispot Add Information to Improve Knowledge on Tropical Diseases?Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus.
P2860
Q26700099-F29BB1CB-9ECE-463E-B89E-63D8A5F5B713Q26782367-78283723-07F9-414F-8788-38B7FA43142AQ27478400-51337D01-58F9-4364-9B7C-2CC3D242551BQ27485041-B9DF2D40-A36E-4C04-8C57-0EC4F05A3B9DQ27485204-663E574D-DD26-4CFF-9FD9-99C6AA19F027Q27485206-65675769-1E1D-4F64-89D3-9DCF4D11E407Q27485213-C8FAB410-8E54-423C-A802-9540BB06D30CQ27487514-53D44C4D-B1E1-45EF-A458-6A707D54BDAEQ27487555-31DF44D8-79C1-49B7-AA97-C9A6A25EAF01Q27489813-D6A693C9-AA0C-4C10-82B6-4158EF1EEC29Q27489979-B5AC9886-237D-40D7-9C51-6B45FEF191BEQ28388716-15A355D8-C346-496E-95CC-0945E25729DCQ28485408-024746A7-F7DE-46E6-A90D-BF4EE48AD38CQ28740522-935F1A41-EF5D-41B6-9F62-99D02C19F898Q29274569-91C98BDB-C751-4987-BEA1-2A8D30A6D1C5Q33610555-AEEEF935-5B4A-4DBA-A8C8-CC8323EEC78BQ33959381-118BFD16-7E35-4612-BEAC-0E7578F6E6DBQ34062468-27C05AF9-1640-48DD-A81D-1E5BA4201227Q34118209-C4A756F1-F13C-44AE-94F5-748652334DB4Q34335105-9A56D65C-9ED9-4DA7-8007-157656724D0AQ34359311-484F0B23-D868-4C1F-831F-760F035EABD2Q34491896-A9615BB1-227B-4B13-B2C3-0DA9E67D7704Q34635043-7D80633B-0589-49E2-9816-C3BAC0FA7BAAQ34732681-2597E92E-18D3-4A1E-9CE3-F7E1C67C7F79Q34764414-FC90D16C-F7F5-4F44-8FFC-CF3B3179267DQ34885695-2A3545A3-2D08-4908-8CBA-6B718AD7D2D5Q34980404-862E482E-4037-4662-A6AB-BCB9A6516E4DQ35640949-AD0A0B6D-B392-4602-80E1-C42FB40AC00DQ35957424-D0601C4A-6A38-4A19-BE1F-6E60C5C1B451Q36031220-2F858126-0BC1-40A0-A2E3-ADF6F9B35933Q36238729-27E8FBF1-EC38-464D-9441-533D48E7EDA3Q36449587-51BD2EFA-FDE1-4809-A812-9538443A4A37Q37336551-852BFC9D-A9F7-4476-AD99-32F5CA12560CQ37837491-5F7DA0C9-51D6-4159-A61D-1FF789107AC6Q40458016-AB685185-9510-42B3-B11F-7431A9EBFB0FQ40493325-9EF3EAEA-6DCF-4BEF-9310-84E9EB720DB8Q40500672-11C6B56E-130D-4667-A893-BE2BF5E433BAQ41928044-B39D52C7-12B3-4F89-BDE1-B06274CE3937Q42977902-9F12C279-E067-4276-8F6F-1FBADF07BD11
P2860
Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Human cytotoxic T lymphocyte r ...... and the structural protein E.
@en
type
label
Human cytotoxic T lymphocyte r ...... and the structural protein E.
@en
prefLabel
Human cytotoxic T lymphocyte r ...... and the structural protein E.
@en
P2093
P921
P356
P1433
P1476
Human cytotoxic T lymphocyte r ...... and the structural protein E.
@en
P2093
Francis A Ennis
Mary Dawn T Co
Masanori Terajima
P304
P356
10.1006/VIRO.2001.1255
P407
P577
2002-02-01T00:00:00Z